These compounds may interact with:
5-hydroxytryptamine receptor 3C
Potentially involved in: carcinoma; primary angle-closure glaucoma; autistic disorder; psoriasis; intubation of gastrointestinal tract; gastroesophageal reflux disease; chemotherapy-induced nausea and vomiting; diabetic gastroparesis; gastrointestinal radiography adjunct; prevention of post-operative nausea and vomiting
Disease data sourced from Pharos.